价值医疗的下一阶段:为什么专科主导模式将定义医疗保健的未来
The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare
超过四分之三的健康系统和医院高管计划在未来两年内扩大参与价值医疗(VBC)模式,而2023年这一比例为57%。但尽管势头日益增长,价值医疗尚未完全兑现其在降低费用的同时改善患者健康的承诺。
一个关键挑战是,价值医疗要求医疗服务提供者管理他们通常无法完全看到的患者旅程中的结果。对于管理多种合并症患者的专科医生来说,这个问题尤为严重,因为整个护理旅程中碎片化的可见性会直接影响结果。
医生群体中人工智能使用率的上升为改善患者识别和参与创造了新机会。但仅靠技术是不够的。医疗服务提供者还需要强大的护理基础设施,将洞察转化为及时的干预。
由以下机构呈现赞助文章《自动化医疗实践:围绕人而非文书重新设计护理》通过减少行政负担并围绕人的需求重新设计工作流程,它为最重要的事情创造了空间:临床医生与患者之间的联系。
作者:Michael Blackman,医学博士,工商管理硕士,Greenway Health®首席医疗官价值医疗的下一步演进将取决于专科医疗服务提供者能否对患者风险进行持续可见的监控,而不仅仅是就诊期间的阶段性洞察。
从激励转向价值医疗中的结果
对于医疗服务提供者而言,价值医疗模式的吸引力通常源于经济激励。通过降低总护理成本来获得基于绩效的奖励和分享结余的机会,是推动他们超越按服务收费模式的动力。
然而,实现共享结余要求医疗服务提供者从根本上改变行为和执业范围。这在包括初级保健在内的所有专科中都是如此,但对于管理医疗复杂患者的专科医生而言尤其如此。
赞助文章
人工智能部署在哪些方面最能让支付方受益?
作者:MedCity News
例如,考虑一位管理肾脏疾病患者的肾脏病学家。历史上,肾脏病学的工作流程主要集中在肾功能上,较少关注糖尿病、心血管疾病、高血压和抑郁症等合并症,而这些合并症会驱动患者的总体风险。
然而,在价值医疗模式下,这种碎片化方法往往在最小化可避免费用方面被证明无效。相反,肾脏病学家必须对患者的整体体验负责,与心脏病学家、内分泌学家、社会工作者和营养专家等其他医疗服务提供者和支持资源密切合作,以改善患者结果。
这反映了医疗保健领域朝着解决专科护理成本驱动因素转变的更广泛趋势。患有多种慢性病的患者在医疗保健利用和费用中占据了不成比例的份额,包括所有临床医生就诊次数的64%和医疗保险支出的93%。
当专科医生为医疗复杂患者扮演“四分卫”的角色时,医疗服务提供者和支付方都能从更具成本效益的护理中受益——但成功取决于整个患者旅程中的强协调。
让价值医疗在2026年之后发挥作用需要什么
价值医疗要求医疗服务提供者和支付方都采用更全面的患者健康管理方法。
对于医疗服务提供者而言,这意味着在传统执业范围之外支持患者,并在整个护理连续过程中进行协作。对于支付方而言,这意味着与医疗服务提供者和综合护理团队建立更深入的合作伙伴关系,以减少碎片化和成本压力。
展望未来,专科医生可以通过改善复杂、高成本患者群体的结果,在推进价值医疗方面发挥核心作用。然而,他们必须通过以下几个核心支柱获得赋能:
1.AI智能识别风险并指导医疗服务提供者行动。AI帮助医疗服务提供者从被动护理过渡到主动护理——这是价值医疗模式中的关键转变。对于管理医疗复杂患者的专科医生尤其如此,因为早期干预对于防止可避免的住院和后续费用至关重要。
例如,转录式AI可以实时捕获和整合医患互动,总结关键风险领域并建议下一步最佳行动,例如跟进药物依从性。
当与其他实时数据源(包括临床笔记、EMR信息、实验室结果、药房数据和住院-出院-转院(ADT)信息流)相结合时,医生可以全面了解就诊之间出现的风险。
凭借持续的患者洞察,专科医生可以与辅助护理团队一起主动干预并满足患者需求,而不是应对急性事件。
2.护理协调以解决治疗障碍。虽然AI能够呈现患者风险和护理差距,但有意识的护理协调将洞察转化为行动。
考虑到血液透析患者大约会错过10%的治疗,其中超过一半的错过治疗是由于缺席。在许多情况下,这些缺席与缺乏交通或护理人员支持有限等因素有关。
一个综合的患者护理团队可以通过帮助安排交通来解决这一依从性障碍,从而支持肾脏病学家。同样,与营养顾问和社会工作者等资源协调可以帮助管理特定的患者合并症。
随着AI支持及时的风险检测,专科医生将越来越依赖这些多学科护理团队的专业知识,以提供能够改善临床结果和成本绩效的针对性干预。
3.持续、数字优先的患者参与。阶段性护理模式不适合医疗复杂人群,这使得持续的患者可见性变得越来越重要。
面向患者的应用程序可以通过捕获体重变化等指标数据来支持远程监测,这些数据可能提示需要干预。同样,双向短信可以帮助护理团队实时与患者联系,无论是确认即将到来的预约还是协调交通。
虚拟参与还可以让患者家庭环境和日常挑战可见。在虚拟就诊期间,专科医生和辅助护理团队可能会识别出患者未明确表达的护理障碍,包括行动不便或护理人员支持有限。
通过在临床环境之外实现持续的沟通和监督,数字工具可以支持专科医生推动患者依从性并改善长期护理结果。同样重要的是,它们可以增强患者体验本身。
释放价值医疗的承诺
价值医疗提供了一条可持续降低医疗保健成本同时保持患者更健康的途径。但没有互联、数字优先的护理交付,实现这一承诺是不可能的。
价值医疗的未来将取决于能否为医疗服务提供者,尤其是专科医生,提供数据和战略合作伙伴关系,以便在传统临床环境之外主动管理患者健康。
通过将先进技术与综合护理交付相结合,价值医疗模式可以从承诺走向实践——甚至为最复杂的患者群体取得更好的结果。
照片来源:nevarpp,Getty Images Paul Marchetti Paul Marchetti是Strive Health的总裁。作为Strive的总裁,Paul负责运营、客户成功和增长。在加入Strive之前,Paul曾担任Elevance Health旗下CarelonRx的总裁,领导药房部门实现大幅增长,在三年内将其价值提升至超过350亿美元,并收购了关键资产,如
More than three-quarters of health system and hospital executives plan to expand participation in value-based care (VBC) models over the next two years, up from 57% in 2023. But despite growing momentum, value-based care has yet to fully deliver on its promise of improving patient health while reducing costs.
A key challenge is that value-based care asks providers to manage outcomes across a patient journey they often cannot fully see. This issue is especially acute for specialists managing patients with multiple comorbidities, where fragmented visibility across the care journey can directly impact outcomes.
The
rise of AI use among physicians creates new opportunities to improve patient identification and engagement. But technology alone isn’t enough. Providers also need robust care infrastructure to translate insights into timely intervention.
By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®
The next evolution of value-based care will depend on whether specialist providers can operate with continuous visibility into patient risk, not just episodic insight during office visits.
Moving from incentives to outcomes in value-based care
For providers, the appeal of value-based care models often stems from financial incentives. The opportunity to earn performance-based rewards and share in savings by reducing the total cost of care is a motivator to move beyond fee-for-service models.
Yet, realizing shared savings requires providers to fundamentally change their behavior and scope of practice. This is true across specialties, including primary care, but particularly for specialists managing medically complex patients.
Sponsored Post
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
By MedCity News
For example, consider a nephrologist managing patients with kidney disease. Historically, nephrology workflows have been focused around kidney function, with less attention on comorbidities such as diabetes, cardiovascular disease, hypertension and depression that drive total patient risk.
In a value-based care model, however, this fragmented approach often proves ineffective at minimizing avoidable costs. Instead, the nephrologist must take accountability for the full patient experience, working closely with other providers and support resources such as cardiologists, endocrinologists, social workers and nutrition specialists to improve patient outcomes.
This reflects a broader shift in the healthcare landscape toward addressing speciality care cost drivers. Patients with multiple chronic conditions account for a disproportionate share of healthcare utilization and costs, including 64% of all clinician visits and 93% of Medicare spending.
When specialists act as “quarterbacks” for medically complex patients, providers and payors alike can benefit from more cost-effective care — but success depends on strong coordination across the patient journey.
What it will take to make value-based care work beyond 2026
Value-based care requires both providers and payors to embrace a more holistic approach to patient health management.
For providers, this means supporting patients beyond their traditional scope of practice and collaborating across the care continuum. For payors, it means building deeper partnerships with providers and integrated care teams to reduce fragmentation and cost pressures.
Going forward, specialists can play a central role in advancing value-based care by improving outcomes for complex, high-cost patient populations. However, they must be empowered through several core pillars:
1.
AI intelligence to identify risk and guide provider action
. AI helps providers transition from reactive to proactive care — a critical shift in value-based models. This is especially true for specialists managing medically complex patients, where early intervention is essential to prevent avoidable hospitalizations and downstream costs.
For example, transcriptional AI can capture and synthesize physician-patient interactions in real time, summarizing key risk areas and suggesting next best actions, such as a follow-up on medication adherence.
When combined with other real-time data sources, including clinical notes, EMR information, lab results, pharmacy data and hospital admission-discharge-transfer (ADT) feeds, physicians gain a comprehensive view of emerging risks between visits.
With access to continuous patient insights, specialists can work alongside supporting care teams to proactively intervene and meet patient needs rather than respond to acute events.
2.
Care coordination to address barriers to treatment
. While AI can surface patient risks and care gaps, intentional care coordination turns insight into action.
Consider the fact that hemodialysis patients miss approximately 10% of treatments, with over half of missed treatments due to absences. In many cases, these absences are tied to factors such as lack of transportation or limited caregiver support.
An integrated patient care team can support nephrologists by helping arrange transportation and address this adherence barrier. Likewise, coordination with resources like nutritional counselors and social workers can help manage specific patient comorbidities.
As AI supports timely risk detection, specialists will increasingly rely on the expertise of these multidisciplinary care teams to deliver targeted interventions that improve both clinical outcomes and cost performance.
3.
Continuous, digital-first patient engagement
. Episodic care models are poorly suited for medically complex populations, which makes continuous patient visibility increasingly important.
Patient-facing applications can support remote monitoring by capturing data on indicators, such as weight changes, that may signal an intervention need. Similarly, bi-directional texting can help care teams connect with patients in real time, whether to confirm upcoming appointments or coordinate transportation.
Virtual engagement can also offer visibility into patients’ home environments and day-to-day challenges. During virtual visits, specialists and supporting care teams may identify barriers to care that patients don’t explicitly communicate, including mobility limitations or limited caregiver support.
By enabling consistent communication and oversight outside the clinical setting, digital tools can support specialists to drive patient adherence and improve long-term care outcomes. Just as importantly, they can strengthen the patient experience itself.
Unlocking the promise of value-based care
Value-based care offers a path to sustainably reduce healthcare costs while keeping patients healthier. But achieving that promise isn’t possible without connected, digital-first care delivery.
The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health beyond traditional clinical settings.
By aligning advanced technology and integrated care delivery, value-based models can move from promise to practice — and achieve better results for even our most complex patient populations.
Photo: nevarpp, Getty Images Paul Marchetti Paul Marchetti is the President of Strive Health. As Strive’s President, Paul oversees operations, customer success and growth. Before joining Strive, Paul served as President of CarelonRx at Elevance Health, where he led the pharmacy division through substantial growth, increasing its value to over $35 billion in three years as well as acquiring key assets like BioPlus, Paragon Healthcare and Kroger Specialty Pharmacy. Earlier in his career, Paul held senior executive roles at New Century Health, Aetna and United where he drove revenue growth, managed national provider and value-based networks, scaled clinical operations and strategic M&A efforts. Paul has a BAS in Healthcare Administration and Management from Springfield College and an MBA in Healthcare Management from the University of New Haven.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers.
Click here to find out how